Restoration of posterior teeth by narrow diameter implants in hyperglycemic and normoglycemic patients – 4-year results of a case-control study
Clinical Oral Investigations · 2024
DOI: 10.1007/s00784-024-05786-0 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Clinical Oral Investigations, 2024. Verfasst von Daniel Diehl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, School of Dentistry, Faculty of Health, Witten/, Herdecke University, Alfred-Herrhausen Str. 45, 58455, Witten, Germany…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Dental Prosthesis Design. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private Universität Witten/Herdecke gGmbH.
Abstract (Originalsprache)
Objectives
To investigate the four-year clinical outcome and marginal bone loss around narrow-diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals. Materials and methods In 11 T2DM patients with a concentration of glycated hemoglobin (HbA1C) > 6.5% (test group) and 15 normoglycemic patients (HbA1C < 6.0%; control group), one narrow-diameter tissue level implant, placed in the posterior maxilla or mandible, was investigated. The clinical parameters probing depth (PD), bleeding on probing (BOP), attachment loss (CAL), recession, and papilla bleeding index (PBI) were assessed manually after 24 and 48 months of function. The paired digital periapical radiographs were analyzed regarding the change in marginal bone level (MBL) from baseline to 48 months post-op. The technical complications were recorded.
Results
In the T2DM group, 11 patients were available for follow-ups. The overall implant survival rate after 48 months was 100%. The differences in means for the clinical parameters and the MBL between the T2DM and normo-glycemic patients for the observation period were statistically non-significant. No technical complications were recorded.
Conclusions
The study demonstrated an encouraging clinical outcome with ND implants in patients with uncontrolled T2DM compared to non-diabetics after 48 months’ post loading. Clinical relevance Patients with HbA1C > 6.5% may benefit from the treatment with narrow-diameter implants by avoiding complex surgical interventions with augmentation procedures. Registration number (clinicaltrials.gov) NCT04630691
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, School of Dentistry, Faculty of Health, Witten/, Herdecke University, Alfred-Herrhausen Str. 45, 58455, Witten, Germany. Daniel.diehl@uni-wh.de.
- Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), Faculty of Health, Witten/Herdecke University, Stockumer Straße 10, 58453, Witten, Germany. Daniel.diehl@uni-wh.de.
- Department of Periodontology, School of Dentistry, Faculty of Health, Witten/, Herdecke University, Alfred-Herrhausen Str. 45, 58455, Witten, Germany.
- Department of Periodontology, Faculty of Dentistry, Altınbaş University, Zuhuratbaba, İncirli Cd. No:11-A, 34147 Bakırköy, Istanbul, Turkey.
Förderung
- Private Universität Witten/Herdecke gGmbH
Zitieren
APA
Diehl, D., Bespalov, A., Yildiz, M. S., & Friedmann, A. (2024). Restoration of posterior teeth by narrow diameter implants in hyperglycemic and normoglycemic patients – 4-year results of a case-control study. Clinical Oral Investigations. https://doi.org/10.1007/s00784-024-05786-0
Vancouver
Diehl D, Bespalov A, Yildiz MS, Friedmann A. Restoration of posterior teeth by narrow diameter implants in hyperglycemic and normoglycemic patients – 4-year results of a case-control study. Clinical Oral Investigations. 2024. doi:10.1007/s00784-024-05786-0
BibTeX
@article{Diehl2024,
author = {Diehl, Daniel and Bespalov, Angelina and Yildiz, Mehmet Selim and Friedmann, Anton},
title = {Restoration of posterior teeth by narrow diameter implants in hyperglycemic and normoglycemic patients – 4-year results of a case-control study},
journal = {Clinical Oral Investigations},
year = {2024},
doi = {10.1007/s00784-024-05786-0}
}
EUVIMED